New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

Illuccix's broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the ...

Despite past setbacks, Zymeworks' partnerships, potential milestones, and large target markets present significant upside ...

Zurich (Switzerland), - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced ...

Puma Biotechnology, Inc. , a biopharmaceutical company, announced that clinical data on neratinib were presented in a poster session at the American Association for Cancer Research (AACR) Annual ...

The full abstracts will be available on the EASL Congress website from 08:30AM CEST on 7 th May 2025. Email: [email protected] Email: [email protected] ...

Zymeworks' financial stability is evident with $76.3 million in revenue in 2024 and a cash runway extending through late 2027 ...

Adults with mild autonomous cortisol secretion show a significant reduction in vertebral fracture risk following ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Professor Ioana Agache discusses how clinicians can improve asthma management by following the new EAACI guideline on indoor ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy ...